21
total announcements
524654.BO · 15 min delayed
Natural Capsules Ltd
Natural Capsules Ltd has published a newspaper advertisement for the completion of dispatch of a corrigendum notice of an extraordinary general meeting (EGM) scheduled to be held on September 9, 2026.
Natural Capsules Ltd
Natural Capsules Ltd has dispatched a Corrigendum to the EGM Notice to all eligible members, incorporating changes in the issue price and quantity of Equity Shares and Convertible Warrants proposed to be issued on a preferential basis.
Natural Capsules Ltd
Natural Capsules Ltd has approved the revised price and quantity of equity shares and convertible warrants for a preferential issue, and also approved the corrigendum notice for an extraordinary general meeting.
Natural Capsules Ltd
Natural Capsules Ltd has informed BSE that a Board Meeting is scheduled on 02/09/2026 to consider and approve the valuation report, revise the issue/allotment price and quantity, and approve the revised notice & schedule for the proposed preferential issue of equity shares/securities.
Natural Capsules Ltd
Natural Capsules Ltd has completed the electronic dispatch of Notice of Extraordinary General Meeting (EGM) and published the same in newspapers. The EGM is scheduled to be held on September 09, 2026, through Video Conferencing (VC) / Other Audio Visual Means (OAVM).
Natural Capsules Ltd
Natural Capsules Ltd has announced a notice for attention of equity shareholders regarding an Extraordinary General Meeting to be held on September 09, 2026, through Video Conferencing (VC) / Other Audio Visual Means (OAVM).
Natural Capsules Ltd
Natural Capsules Ltd has fixed the record date for its extraordinary general meeting (EGM) on September 2nd, 2026, and the EGM will be held on September 9th, 2026.
Natural Capsules Ltd
Natural Capsules Ltd has announced a Notice of Extraordinary General Meeting (EGM) to be held on September 09, 2026, to consider a preferential issue of 1,25,000 equity shares at Rs. 160/- per share, aggregating to Rs. 2,00,00,000.
Natural Capsules Ltd
Natural Capsules Ltd has announced the resignation of Mr. Pramod Kasat as Independent Director of its material unlisted subsidiary, Natural Biogenex Private Limited, effective August 17, 2026.
Natural Capsules Ltd
Natural Capsules Ltd approved unaudited consolidated & standalone financial results for Q1 2026, also announced preferential issue of warrants to promoters at ₹160 per share.
Natural Capsules Ltd
Natural Capsules Ltd published unaudited financial results for Q1 2026, with revenue and profit before tax increasing 16% and 7% year-over-year, respectively. The company's Africa business grew 44% and 21% in revenue and profit, respectively. Gokaldas Exports, a related party, secured India's largest single-cluster Al infrastructure for the US-based cloud innovator Together AL.
Natural Capsules Ltd
Natural Capsules Ltd has announced the voting results and scrutinizer's report of its 33rd AGM, which was held on August 12, 2026, through video conferencing. The company has complied with the relevant regulations and circulars issued by the Ministry of Corporate Affairs and the Institute of Company Secretaries of India.
Natural Capsules Ltd
Natural Capsules Ltd has released its Q1FY27 financial results, showing revenue of ₹48.71 Cr, EBITDA of ₹1.12 Cr, and PAT of ₹-5.74 Cr. The company witnessed sustained demand across its capsule products and improved realisations, but faced challenges in the HPMC segment due to US market uncertainty and geopolitical issues in the APl business.
Natural Capsules Ltd
Natural Capsules Ltd reported its Q1FY27 results, with revenue of ₹4871 Cr, EBITDA of ₹1.12 Cr, and EBITDA margins of 2.30%. The company witnessed sustained demand across its capsule products and improved realisations, but faced challenges in the HPMC segment due to uncertainty in the US market. The API business presented a mixed picture, with ongoing geopolitical uncertainty and headwinds from the depreciation of the Indian rupee.
Natural Capsules Ltd
Natural Capsules Ltd has appointed Mr. K. H. Honneshaiah as the new Chief Operating Officer of its Material Unlisted Subsidiary, Natural Biogenex Private Limited.
Natural Capsules Ltd
Natural Capsules Ltd approved its unaudited Consolidated & Standalone Financial Results for Q1 2026 and announced a preferential issue of equity shares and warrants to its promoter group.
Natural Capsules Ltd
Natural Capsules Ltd held its 33rd Annual General Meeting on August 12, 2026, where the company's audited consolidated and standalone financial statements for the year ended March 31, 2026, were adopted, and several resolutions were passed, including the reappointment of directors, revision of remuneration, and approval of related party transactions.
Natural Capsules Ltd
Natural Capsules Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/08/2026 to consider and approve the unaudited consolidated & standalone financial results for the quarter ended June 30, 2026, and also to evaluate a proposal for raising funds by way of issue of equity shares, convertibles, and/or any other eligible securities on a preferential basis.
Natural Capsules Ltd
Natural Capsules Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 to consider and approve the unaudited consolidated & standalone financial results of the Company for the quarter ended June 30th, 2026.
Natural Capsules Ltd
Natural Capsules Ltd's material unlisted subsidiary, Natural Biogenex Private Limited, has approved the allotment of 946,305 equity shares for a cash consideration of ₹94,63,050.